Any current/future new fundraising through debt or equity?

The company currently has a strong cash position of close to INR 200 crores as of December 31, 2025. They can also avail certain debt if needed for acquisitions or expansion. Internal accruals are strong, enabling the company to fund capital expenditure for the next 3 years. Fund deployment of INR 1,500 crores capex for reaching 5,000 beds will be spread over 5 years. Acquisitions are planned over the coming years and will be funded through a mix of cash, debt, and internal accruals. No specific mention of an immediate upcoming fundraising through equity or debt, but plans include leveraging v

Any current/future capex/capital investment/strategic investment?

Yatharth Hospitals plans a total capex of around INR 1,500 crores over the next 4-5 years. The capex aims to add close to 5,000 beds within the next 3-3.5 years. Expansion will be a mix of greenfield, brownfield, and asset-light models, with capex per bed around INR 60 lakhs on average. Specific greenfield and brownfield additions include 500 brownfield beds in Noida and Noida Extension. The company targets major growth in the NCR region and other large cities in North India. Current cash and bank balance is close to INR 200 crores, with plans to use internal accruals and debt for future acqui

Future growth expectations in sales/revenue/volumes?

Company targets reaching close to 5,000 beds in the next 3-4 years with a mix of greenfield, brownfield, and asset-light expansions, mainly in NCR and major North Indian cities. Q4 FY '26 expected to perform better than Q3 with improved EBITDA margins targeting 24-25% consolidated level in FY '27. Existing hospitals showing strong growth; Q3 FY '26 revenue up 46% YoY and 15% QoQ, driven by existing hospitals growing 33% YoY. New hospitals (New Delhi, Faridabad Sector-20) ramping up occupancy with expected breakeven within 12-15 months. Oncology business expected to grow from 10% to aro

Current/ Expected Orderbook/ Pending Orders?

Yatharth Hospitals is targeting to reach close to 5,000 beds in the next 3 years through announced deals. Deployment of these beds will be spread over 4 to 5 years with a mix of greenfield, brownfield, and asset-light expansions. Combined planned capex for this expansion is around INR 1,500 crores, implying approximately INR 60 lakhs per bed. Focus geography for expansion is primarily NCR, followed by major cities in North India. The expansion includes around 2,000 incremental beds with capex of INR 1,500 crores, in addition to 500 beds brownfield expansions already planned at Noida an

IN US

Sale is live|00:00:00left today

Yatharth Hospital & Trauma Care Services LtdQ4 FY27Healthcare Services

Yatharth Hospital & Trauma Care Services Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹837P/E: 47.0Market Cap: ₹7.9K CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 2

Fundraise

Yes

Order

Yes

Capex

Yes

3 of 5 growth signals are positive.

Full analysis

Revenue guidance

Category 2

→Company targets reaching close to 5,000 beds in the next 3-4 years with a mix of greenfield, brownfield, and asset-light expansions, mainly in NCR and major North Indian cities.
→Q4 FY '26 expected to perform better than Q3 with improved EBITDA margins targeting 24-25% consolidated level in FY '27.
→Existing hospitals showing strong growth; Q3 FY '26 revenue up 46% YoY and 15% QoQ, driven by existing hospitals growing 33% YoY.
→New hospitals (New Delhi, Faridabad Sector-20) ramping up occupancy with expected breakeven within 12-15 months.
→Oncology business expected to grow from 10% to around 15% of specialty revenue within 1.5 years, supporting ARPOB and revenue growth.
→ARPOB growing at over 10% YoY with Noida Extension achieving INR44,000 ARPOB, indicating pricing strength and volume growth.
→Medical tourism showing incremental growth potential contributing to revenue expansion.

Margin guidance

Category 2

- Targeting blended EBITDA margin of 24%-25% on a consolidated level for FY '27 amid growth phase (Page 19). - New hospitals (Delhi Model Town, Faridabad Sector-20) expected to reach operational breakeven within 12-15 months, reducing losses and improving margins (Page 18). - EBITDA margin without new hospitals approximately 28%-29%; new hospital additions cause temporary EBITDA drag (Page 17). - ARPOB expected to grow ~10% year-on-year in coming periods, supporting revenue and margin expansion (Page 17). - Revenue growth driven by existing hospitals at 33% YoY; Q3 FY26 revenues at INR3,205 million, up 46% YoY (Page 5). - Net profit after tax up 41% YoY; adjusted PAT up 80% YoY (Page 5). - Capex of INR1,500 crores planned over 5 years to increase bed capacity to 5,000, supporting scalable growth (Pages 19 & 14). Overall, consistent growth in operating earnings and profits is expected, with margin improvement as new hospitals mature.

3 more insights locked — sign up free to unlock

Fundraise plans

Yes

→The company currently has a strong cash position of close to INR 200 crores as of December 31, 2025.
→They can also avail certain debt if needed for acquisitions or expansion.
→Internal accruals are strong, enabling the company to fund capital expenditure for the next 3 years.
→Fund deployment of INR 1,500 crores capex for reaching 5,000 beds will be spread over 5 years.
→Acquisitions are planned over the coming years and will be funded through a mix of cash, debt, and internal accruals.
→No specific mention of an immediate upcoming fundraising through equity or debt, but plans include leveraging various funding sources as required.

Order book

Yes

→Yatharth Hospitals is targeting to reach close to 5,000 beds in the next 3 years through announced deals.
→Deployment of these beds will be spread over 4 to 5 years with a mix of greenfield, brownfield, and asset-light expansions.
→Combined planned capex for this expansion is around INR 1,500 crores, implying approximately INR 60 lakhs per bed.
→Focus geography for expansion is primarily NCR, followed by major cities in North India.
→The expansion includes around 2,000 incremental beds with capex of INR 1,500 crores, in addition to 500 beds brownfield expansions already planned at Noida and Noida Extension.
→Fund deployment for this capex is planned over 5 years.

Capex plans

Yes

→Yatharth Hospitals plans a total capex of around INR 1,500 crores over the next 4-5 years.
→The capex aims to add close to 5,000 beds within the next 3-3.5 years.
→Expansion will be a mix of greenfield, brownfield, and asset-light models, with capex per bed around INR 60 lakhs on average.
→Specific greenfield and brownfield additions include 500 brownfield beds in Noida and Noida Extension.
→The company targets major growth in the NCR region and other large cities in North India.
→Current cash and bank balance is close to INR 200 crores, with plans to use internal accruals and debt for future acquisitions and expansions.
→New hospitals in Faridabad and Delhi have higher capex per bed, around INR 80-90 lakhs.
→Acquisitions will continue over the coming years as part of growth strategy.

How does Yatharth Hospital & Trauma Care Services Ltd rank vs peers in Healthcare Services?

Pro feature

1Yatharth Hospital & Trauma Care Services Ltd

Rev 2Mar 2

See full Healthcare Services sector rankings

Want more stocks like Yatharth Hospital & Trauma Care Services Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio